nCounter® CVD Pathophysiology Panel Grant Program
Let us help you rapidly advance your cardiovascular research!
Apply Now thru October 31st! The Submission Deadline Has Passed!
Enter our grant application program for the chance to receive 24 samples of your choice from either the Human or Mouse nCounter® CVD Pathophysiology Panel. Gain molecular insights from 800 genes across 50 pathways involved in CVD Pathophysiology:
• Cardiovascular Pathology
• Cardiovascular Physiology
• Vascular Inflammation
• Cellular Aging & Renewal
• Mechano Signaling
• Regulatory Signaling
• Epigenetic Remodeling
The CVD panel provides quick, actionable results. Explore how cardiovascular dysfunction contributes to heart disease, hypertension, and arteriosclerosis. Study the cardiotoxic effects of immune therapies or assess the role of aging and cell renewal in cardiac regenerative medicine- all with results in less than 24 hours.
Six total grant winners from around the world will be chosen globally to receive a grant of either Human or Mouse nCounter® CVD Pathophysiology Panel along with all reagents required for the project. Apply today to be the first at your institution to advance your cardiovascular research using this new panel!
Awards will be announced on or before end the of November 2022.
Thanks for your interest. We are no longer accepting applications.
Terms & Conditions:
Publication of Project Results:
All submissions are confidential to the individual submitter and will not be published or distributed; however, NanoString may share them with partners, collaborators and other third parties who are obligated to keep them confidential.
Eligibility and Requirements:
Applicants must be actively enrolled or employed at an institution or company in a capacity in which they perform life science research as a postdoctoral research fellow, research fellow, etc. Recipients must be age 18 or older. Members of the immediate families of NanoString employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this grant program. The grant award allows for the recipient to run 24 samples worth of an nCounter CVD Pathophysiology panel along with samples of Master Kits or Sprint Cartridges, whichever is applicable. Projects can be run at the recipient’s institution on a local nCounter instrument or run through NanoString at our Proof-of-Principle (POP) lab if access to a local instrument is not possible.
By submitting an application, each applicant agrees that NanoString may use his or her name, abstract title, and abstract for marketing purposes. All applicants agree that NanoString may process the personal data he or she provides as part of the application, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at nanostring.com/privacy. Award recipients may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString. No substitution or transfer of the awarded is allowed, except as otherwise permitted by NanoString. Grant winners are responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, this grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose. This program is void where prohibited or otherwise restricted by law. These terms and conditions and any action related to this grant award program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.